Full View

Ivosidenib induces deep durable remissions in patients with newly diagnosed IDH1-mutant acute myeloid leukemia

GJ Roboz, CD DiNardo, EM Stein… - Blood, The Journal …, 2020 - ashpublications.org
Abstract Ivosidenib (AG-120) is an oral, targeted agent that suppresses production of the
oncometabolite 2-hydroxyglutarate via inhibition of the mutant isocitrate dehydrogenase 1 …
被引用次数：335 相关文章
[HTML] sciencedirect.com

[HTML][HTML] Ivosidenib induces deep durable remissions in patients with newly diagnosed IDH1-mutant acute myeloid leukemia

GJ Roboz, CD DiNardo, EM Stein, S de Botton… - Blood, 2020 - Elsevier
Abstract Ivosidenib (AG-120) is an oral, targeted agent that suppresses production of the
oncometabolite 2-hydroxyglutarate via inhibition of the mutant isocitrate dehydrogenase 1 …

Ivosidenib induces deep durable remissions in patients with newly diagnosed IDH1-mutant acute myeloid leukemia.

GJ Roboz, CD DiNardo, EM Stein, S de Botton… - Blood, 2020 - europepmc.org
Abstract Ivosidenib (AG-120) is an oral, targeted agent that suppresses production of the
oncometabolite 2-hydroxyglutarate via inhibition of the mutant isocitrate dehydrogenase 1 …
[HTML] nih.gov

[HTML][HTML] Myeloid Neoplasia: Ivosidenib induces deep durable remissions in patients with newly diagnosed IDH1-mutant acute myeloid leukemia

GJ Roboz, CD DiNardo, EM Stein, S de Botton… - Blood, 2020 - ncbi.nlm.nih.gov
Abstract Ivosidenib (AG-120) is an oral, targeted agent that suppresses production of the
oncometabolite 2-hydroxyglutarate via inhibition of the mutant isocitrate dehydrogenase 1 …

Ivosidenib induces deep durable remissions in patients with newly diagnosed IDH1-mutant acute myeloid leukemia

GJ Roboz, CD DiNardo, EM Stein, S de Botton… - …, 2020 - scholars.northwestern.edu
Abstract Ivosidenib (AG-120) is an oral, targeted agent that suppresses production of the
oncometabolite 2-hydroxyglutarate via inhibition of the mutant isocitrate dehydrogenase 1 …

Ivosidenib induces deep durable remissions in patients with newly diagnosed IDH1-mutant acute myeloid leukemia

GJ Roboz, CD DiNardo, EM Stein… - …, 2020 - mdanderson.elsevierpure.com
Abstract Ivosidenib (AG-120) is an oral, targeted agent that suppresses production of the
oncometabolite 2-hydroxyglutarate via inhibition of the mutant isocitrate dehydrogenase 1 …

Ivosidenib induces deep durable remissions in patients with newly diagnosed IDH1-mutant acute myeloid leukemia

GJ Roboz, CD DiNardo, EM Stein, S de Botton… - …, 2020 - pubmed.ncbi.nlm.nih.gov
Ivosidenib (AG-120) is an oral, targeted agent that suppresses production of the
oncometabolite 2-hydroxyglutarate via inhibition of the mutant isocitrate dehydrogenase 1 …

Ivosidenib induces deep durable remissions in patients with newly diagnosed IDH1-mutant acute myeloid leukemia

GJ Roboz, CD DiNardo, EM Stein, S de Botton… - …, 2020 - ohiostate.elsevierpure.com
Abstract Ivosidenib (AG-120) is an oral, targeted agent that suppresses production of the
oncometabolite 2-hydroxyglutarate via inhibition of the mutant isocitrate dehydrogenase 1 …

Ivosidenib induces deep durable remissions in patients with newly diagnosed IDH1-mutant acute myeloid leukemia

GJ Roboz, CD DiNardo, EM Stein, S de Botton… - Blood, 2020 - cir.nii.ac.jp
抄録< jats: title> Abstract</jats: title>< jats: p> Ivosidenib (AG-120) is an oral, targeted agent
that suppresses production of the oncometabolite 2-hydroxyglutarate via inhibition of the …

Ivosidenib induces deep durable remissions in patients with newly diagnosed IDH1-mutant acute myeloid leukemia

GJ Roboz, CD DiNardo, EM Stein, S de Botton… - Blood, 2020 - profiles.wustl.edu
Abstract Ivosidenib (AG-120) is an oral, targeted agent that suppresses production of the
oncometabolite 2-hydroxyglutarate via inhibition of the mutant isocitrate dehydrogenase 1 …